You have no items in your shopping cart.
Filtered Products
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.7 KDa. Observed: 60-80 KDa, reducing conditions
Human
Ala27-Asp239
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 25.6 KDa. Observed: 35-40 KDa, reducing conditions
Human
Ala27-Asp239
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 48.9 KDa. Observed: 60-80 KDa, reducing conditions
Human
Glu22-Cys213
C-Fc
50 μg, 10 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 35-44 KDa, reducing conditions
Human
Glu22-Cys213
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.3 KDa. Observed: 55-60 KDa, reducing conditions
Human
Gln21-Asn203
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 85.6 KDa. Observed: 90-120 KDa, reducing conditions
Human
Val20-Thr547
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 78.5 KDa. Observed: 95-120 KDa, reducing conditions
Human
Val19-Ser482
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.6 KDa. Observed: 25-35 KDa, reducing conditions
Human
Tyr17-Thr135
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 99.3 KDa. Observed: 115-125 KDa, reducing conditions
Mouse
Ala21-Gly664
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 41.1 KDa. Observed: 42-58 KDa, reducing conditions
Mouse
Tyr20-Glu140
C-Fc
10 μg, 50 μg, 500 μg, 1 mg
